---
document_datetime: 2025-11-23 13:22:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/nuedexta.html
document_name: nuedexta.html
version: success
processing_time: 0.1156724
conversion_datetime: 2025-12-24 02:43:45.764446
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Nuedexta

[RSS](/en/individual-human-medicine.xml/66571)

##### Withdrawn

This medicine's authorisation has been withdrawn

dextromethorphan hydrobromide / quinidine sulfate

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Nuedexta](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 15 February 2016 the European Commission withdrew the marketing authorisation for Nuedexta (dextromethorphan / quinidine) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Jenson Pharmaceutical Services Ltd, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Nuedexta was granted marketing authorisation in the EU on 24 June 2013 for treatment of pseudobulbar affect (PBA) in adults. The product had not been marketed in the EU.

The European Public Assessment Report (EPAR) for Nuedexta is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Nuedexta : EPAR - Summary for the public

Reference Number: EMA/367786/2013

English (EN) (193.76 KB - PDF)

**First published:** 02/07/2013

**Last updated:** 02/07/2013

[View](/en/documents/overview/nuedexta-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-30)

български (BG) (312.89 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/bg/documents/overview/nuedexta-epar-summary-public_bg.pdf)

español (ES) (266.25 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/es/documents/overview/nuedexta-epar-summary-public_es.pdf)

čeština (CS) (293.48 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/cs/documents/overview/nuedexta-epar-summary-public_cs.pdf)

dansk (DA) (266.6 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/da/documents/overview/nuedexta-epar-summary-public_da.pdf)

Deutsch (DE) (267.83 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/de/documents/overview/nuedexta-epar-summary-public_de.pdf)

eesti keel (ET) (269.56 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/et/documents/overview/nuedexta-epar-summary-public_et.pdf)

ελληνικά (EL) (320.31 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/el/documents/overview/nuedexta-epar-summary-public_el.pdf)

français (FR) (267.84 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/fr/documents/overview/nuedexta-epar-summary-public_fr.pdf)

hrvatski (HR) (283.73 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/hr/documents/overview/nuedexta-epar-summary-public_hr.pdf)

italiano (IT) (264.25 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/it/documents/overview/nuedexta-epar-summary-public_it.pdf)

latviešu valoda (LV) (302.74 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/lv/documents/overview/nuedexta-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (283 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/lt/documents/overview/nuedexta-epar-summary-public_lt.pdf)

magyar (HU) (284.97 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/hu/documents/overview/nuedexta-epar-summary-public_hu.pdf)

Malti (MT) (290.76 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/mt/documents/overview/nuedexta-epar-summary-public_mt.pdf)

Nederlands (NL) (264.69 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/nl/documents/overview/nuedexta-epar-summary-public_nl.pdf)

polski (PL) (284.4 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/pl/documents/overview/nuedexta-epar-summary-public_pl.pdf)

português (PT) (286.28 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/pt/documents/overview/nuedexta-epar-summary-public_pt.pdf)

română (RO) (268.86 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/ro/documents/overview/nuedexta-epar-summary-public_ro.pdf)

slovenčina (SK) (285.42 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/sk/documents/overview/nuedexta-epar-summary-public_sk.pdf)

slovenščina (SL) (286.75 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/sl/documents/overview/nuedexta-epar-summary-public_sl.pdf)

Suomi (FI) (262.95 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/fi/documents/overview/nuedexta-epar-summary-public_fi.pdf)

svenska (SV) (265.02 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/sv/documents/overview/nuedexta-epar-summary-public_sv.pdf)

## Product information

Nuedexta : EPAR - Product Information

English (EN) (635.09 KB - PDF)

**First published:** 02/07/2013

**Last updated:** 26/11/2014

[View](/en/documents/product-information/nuedexta-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-462)

български (BG) (1.24 MB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/bg/documents/product-information/nuedexta-epar-product-information_bg.pdf)

español (ES) (638.47 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/es/documents/product-information/nuedexta-epar-product-information_es.pdf)

čeština (CS) (994 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/cs/documents/product-information/nuedexta-epar-product-information_cs.pdf)

dansk (DA) (630.24 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/da/documents/product-information/nuedexta-epar-product-information_da.pdf)

Deutsch (DE) (690.2 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/de/documents/product-information/nuedexta-epar-product-information_de.pdf)

eesti keel (ET) (627.09 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/et/documents/product-information/nuedexta-epar-product-information_et.pdf)

ελληνικά (EL) (1.36 MB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/el/documents/product-information/nuedexta-epar-product-information_el.pdf)

français (FR) (691.37 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/fr/documents/product-information/nuedexta-epar-product-information_fr.pdf)

hrvatski (HR) (642.16 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/hr/documents/product-information/nuedexta-epar-product-information_hr.pdf)

íslenska (IS) (955.72 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/is/documents/product-information/nuedexta-epar-product-information_is.pdf)

italiano (IT) (651.76 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/it/documents/product-information/nuedexta-epar-product-information_it.pdf)

latviešu valoda (LV) (994.32 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/lv/documents/product-information/nuedexta-epar-product-information_lv.pdf)

lietuvių kalba (LT) (810.7 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/lt/documents/product-information/nuedexta-epar-product-information_lt.pdf)

magyar (HU) (994.57 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/hu/documents/product-information/nuedexta-epar-product-information_hu.pdf)

Malti (MT) (1.04 MB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/mt/documents/product-information/nuedexta-epar-product-information_mt.pdf)

Nederlands (NL) (663.87 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/nl/documents/product-information/nuedexta-epar-product-information_nl.pdf)

norsk (NO) (943.33 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/no/documents/product-information/nuedexta-epar-product-information_no.pdf)

polski (PL) (1.71 MB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/pl/documents/product-information/nuedexta-epar-product-information_pl.pdf)

português (PT) (649.06 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/pt/documents/product-information/nuedexta-epar-product-information_pt.pdf)

română (RO) (655.52 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/ro/documents/product-information/nuedexta-epar-product-information_ro.pdf)

slovenčina (SK) (976.88 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/sk/documents/product-information/nuedexta-epar-product-information_sk.pdf)

slovenščina (SL) (925.24 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/sl/documents/product-information/nuedexta-epar-product-information_sl.pdf)

Suomi (FI) (653.71 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/fi/documents/product-information/nuedexta-epar-product-information_fi.pdf)

svenska (SV) (642.3 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

26/11/2014

[View](/sv/documents/product-information/nuedexta-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0005 24/10/2014

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Nuedexta : EPAR - All Authorised presentations

English (EN) (159.57 KB - PDF)

**First published:** 02/07/2013

**Last updated:** 02/07/2013

[View](/en/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-895)

български (BG) (167.05 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/bg/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_bg.pdf)

español (ES) (153.71 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/es/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_es.pdf)

čeština (CS) (160.1 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/cs/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (154.47 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/da/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (154.57 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/de/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (153.66 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/et/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (177.22 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/el/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_el.pdf)

français (FR) (153.69 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/fr/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (282.98 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/hr/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (169.64 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/is/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_is.pdf)

italiano (IT) (152.66 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/it/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (164.45 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/lv/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (154.89 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/lt/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (160.64 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/hu/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (160.78 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/mt/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (153.75 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/nl/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (170.1 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/no/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_no.pdf)

polski (PL) (159.71 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/pl/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_pl.pdf)

português (PT) (154.08 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/pt/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_pt.pdf)

română (RO) (153.69 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/ro/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (159.39 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/sk/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (157.93 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/sl/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (152.94 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/fi/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (136.89 KB - PDF)

**First published:**

02/07/2013

**Last updated:**

02/07/2013

[View](/sv/documents/all-authorised-presentations/nuedexta-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Nuedexta Active substance

- dextromethorphan
- quinidine

International non-proprietary name (INN) or common name

- dextromethorphan hydrobromide
- quinidine sulfate

Therapeutic area (MeSH) Neurobehavioral Manifestations Anatomical therapeutic chemical (ATC) code N07XX59

### Pharmacotherapeutic group

Other nervous system drugs

### Therapeutic indication

Nuedexta is indicated for the symptomatic treatment of pseudobulbar affect (PBA) in adults. Efficacy has only been studied in patients with underlying amyotrophic lateral sclerosis or multiple sclerosis.

## Authorisation details

EMA product number EMEA/H/C/002560 Marketing authorisation holder

Jenson Pharmaceutical Services Limited

Carradine House

Marketing authorisation issued 24/06/2013 Withdrawal of marketing authorisation 15/02/2016 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Nuedexta : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (204.51 KB - PDF)

**First published:** 13/08/2014

**Last updated:** 26/11/2014

[View](/en/documents/procedural-steps-after/nuedexta-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Nuedexta : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/80029/2013

English (EN) (2.11 MB - PDF)

**First published:** 02/07/2013

**Last updated:** 02/07/2013

[View](/en/documents/assessment-report/nuedexta-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Nuedexta

Adopted

Reference Number: EMA/CHMP/132029/2013

English (EN) (244.66 KB - PDF)

**First published:** 26/04/2013

**Last updated:** 26/04/2013

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-nuedexta_en.pdf)

#### News on Nuedexta

[European Medicines Agency recommends approval of first treatment for pseudobulbar affect](/en/news/european-medicines-agency-recommends-approval-first-treatment-pseudobulbar-affect) 26/04/2013

**This page was last updated on** 11/03/2016

## Share this page

[Back to top](#main-content)